​In healthcare, intravenous antibiotics are widely regarded as a frontline defense, essential for neutralizing life-threatening bacterial infections and restoring patient stability. However, when the very treatments intended to heal instead provoke severe clinical harm, the system faces a critical test of public safety and institutional accountability. The recent investigation launched[Read More…]